OR WAIT null SECS
In this episode of Drug Digest, Pharmaceutical Technology’s European/Senior Editor, Felicity Thomas, chats about the biggest trends impacting oral and topical drug delivery and how these trends are impacting the excipient sector with Nick DiFranco and Ashley Rezak from Lubrizol Life Science Health.
In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews experts innovations in oral and topical drug delivery. During the video, Ashley Rezak and Nick DiFranco from Lubrizol Life Science Health look at the overarching oral and topical drug delivery trends and how these are impacting excipient innovation in particular. Mucoadhesion and solubility/bioavailability enhancement are particularly focused upon during the chat, with Ashley and Nick wrapping up the conversation about hindrances to the excipient sector and ways that recent developments, such as CDER’s pilot review program, are helping industry to overcome these difficulties.
Nick DiFranco, MEM, Global Market Segment Manager for Oral Drug Delivery at Lubrizol Life Science Health
Nick DiFranco, MEM, is the Global Market Segment Manager for Oral Drug Delivery at Lubrizol Life Science Health. In his role, Nick coordinates a multi-disciplinary team offering excipients and services for controlled release and solubility enhancement in oral solids and liquids, including Carbopol and Apinovex polymers. Prior to this role, Nick held positions as an Applications Scientist and Market Manager at Lubrizol supporting long-acting drug delivery and CDMO services. Nick holds a BS in Biomedical Engineering (Biomaterials focus) and a Master of Engineering and Management degree from Case Western Reserve University.
Ashley Rezak, Global Market Manager—Topical Drug Delivery for the Pharmaceutical Excipients division at Lubrizol Life Science Health
Ashley Rezak currently serves as the Global Market Manager—Topical Drug Delivery for the Pharmaceutical Excipients division of Lubrizol Life Science Health. She obtained her BSE in Biomedical Engineering, with a minor in Polymer Engineering, from Case Western Reserve University. Ashley joined Lubrizol in 2018 and has held several roles with the company since then. She is currently responsible for marketing, business development, and strategy efforts pertaining to topical pharmaceutical ingredients.
This episode of Drug Digest is sponsored by:
Drug Digest is a tech talk video series with the Pharmaceutical Technology editors, who interview industry experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.